Asansol Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.50 M
as on 14-12-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 231.16%
(FY 2023)
- Profit -0.12%
(FY 2023)
- Ebitda -9.39%
(FY 2023)
- Net Worth -235.74%
(FY 2023)
- Total Assets 7.04%
(FY 2023)
About Asansol Healthcare
The Corporate was formerly known as Aastha Inn Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anirban Chatterjee, Santanu Sarkar, and Ajoy Mukhopadhyay serve as directors at the Company.
- CIN/LLPIN
U85100WB2012PLC180587
- Company No.
180587
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asansol Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirban Chatterjee  | Director | 10-Mar-2023 | Current |
| Santanu Sarkar | Director | 24-Mar-2016 | Current |
| Ajoy Mukhopadhyay | Director | 10-Mar-2023 | Current |
Financial Performance of Asansol Healthcare.
Asansol Healthcare Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 231.16% increase. The company also saw a slight decrease in profitability, with a 0.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 235.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asansol Healthcare?
In 2023, Asansol Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asansol Astha It Projects Private LimitedActive 13 years 10 monthsSantanu Sarkar is a mutual person
Incite (India) Construction Private LimitedActive 17 years 4 monthsAnirban Chatterjee is a mutual person
- Aastha Finance & Investment LimitedActive 14 years 7 months
Anirban Chatterjee and Santanu Sarkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asansol Healthcare?
Unlock and access historical data on people associated with Asansol Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asansol Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asansol Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
